Product Code: ETC334764 | Publication Date: Aug 2022 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India neomycin sulfate market import shipment demonstrated a marginal Compound Annual Growth Rate (CAGR) from 2020 to 2024. However, there was a slight decline in growth rate between 2023 and 2024. Overall, the market exhibited a relatively stable growth trend with a slight deceleration in momentum towards the end of the period.
The neomycin sulfate market in India is projected to grow at a CAGR of 10% from 2025 to 2025 due to increased usage in pharmaceuticals and animal health products. Neomycin sulfate is an antibiotic that inhibits bacterial protein synthesis and helps prevent infection caused by gram-negative bacilli such as E coli or Pseudomonas aeruginosa. Increasing prevalence of diseases among both humans and animals has driven the demand for neomycin sulfate significantly over recent years. Furthermore, development of novel drugs like topical ointments containing neomycin sulfates can also create potential opportunities for manufacturers operating in this space over the forecast period (2025?2025).
The India neomycin sulfate market is expected to experience growth driven by various factors. Neomycin sulfate is a widely used antibiotic in the pharmaceutical and healthcare sectors. The prevalence of bacterial infections and the continuous need for effective antibiotics contribute to the demand for neomycin sulfate. Additionally, the growing healthcare infrastructure and increasing awareness about proper medication are likely to support the market`s growth. However, challenges such as antibiotic resistance and regulatory considerations may impact the market`s dynamics.
The India neomycin sulfate market serves pharmaceutical and veterinary applications. However, challenges exist. The overuse or improper use of antibiotics, including neomycin sulfate, contributes to the growing concern of antimicrobial resistance. Regulatory agencies are tightening regulations on antibiotic use, impacting the market. Balancing the need for effective treatments while addressing antibiotic resistance poses a significant challenge for pharmaceutical companies.
The India neomycin sulfate market, as a pharmaceutical ingredient, witnessed changes in demand patterns due to the pandemic. While the demand for antibiotics remained steady, disruptions in supply chains and manufacturing affected the availability of certain medications. The market`s recovery is contingent on stable supply chains and continued healthcare needs.
The India neomycin sulfate market is driven by its use in the pharmaceutical and veterinary industries. Key players like Sun Pharmaceutical Industries, Cadila Healthcare, and Lasa Supergenerics are prominent in this market. These companies are known for their pharmaceutical formulations, including antibiotics like neomycin sulfate, catering to the healthcare needs of both humans and animals.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Neomycin Sulfate Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Neomycin Sulfate Market Revenues & Volume, 2021 & 2031F |
3.3 India Neomycin Sulfate Market - Industry Life Cycle |
3.4 India Neomycin Sulfate Market - Porter's Five Forces |
3.5 India Neomycin Sulfate Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Neomycin Sulfate Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Neomycin Sulfate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in India |
4.2.2 Growing demand for antibiotics in the healthcare sector |
4.2.3 Rise in awareness about the effectiveness of neomycin sulfate in treating various infections |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines for the use of antibiotics in India |
4.3.2 Concerns regarding antibiotic resistance and misuse |
4.3.3 Competition from alternative antibiotics in the market |
5 India Neomycin Sulfate Market Trends |
6 India Neomycin Sulfate Market, By Types |
6.1 India Neomycin Sulfate Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Neomycin Sulfate Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 India Neomycin Sulfate Market Revenues & Volume, By Cream, 2021-2031F |
6.1.4 India Neomycin Sulfate Market Revenues & Volume, By Ointment, 2021-2031F |
6.1.5 India Neomycin Sulfate Market Revenues & Volume, By Others, 2021-2031F |
6.2 India Neomycin Sulfate Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 India Neomycin Sulfate Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.2.3 India Neomycin Sulfate Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.2.4 India Neomycin Sulfate Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 India Neomycin Sulfate Market Import-Export Trade Statistics |
7.1 India Neomycin Sulfate Market Export to Major Countries |
7.2 India Neomycin Sulfate Market Imports from Major Countries |
8 India Neomycin Sulfate Market Key Performance Indicators |
8.1 Number of prescriptions including neomycin sulfate |
8.2 Percentage increase in production capacity of neomycin sulfate manufacturers |
8.3 Research and development investment in new formulations or applications of neomycin sulfate |
9 India Neomycin Sulfate Market - Opportunity Assessment |
9.1 India Neomycin Sulfate Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Neomycin Sulfate Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Neomycin Sulfate Market - Competitive Landscape |
10.1 India Neomycin Sulfate Market Revenue Share, By Companies, 2024 |
10.2 India Neomycin Sulfate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |